Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer

Published:2017-02 Issue: Volume:386 Page:24-34
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ji Xuemei,Peng Zhengxin,Li Xiaorui,Yan Zhonghui,Yang Yue,Qiao Zheng,Liu Yu

Funder

Fundamental Research Funds for the Central Universities Institutions

National Science and Technology Major Project

National High Technology Research and Development Program 863

Natural Science Foundation of Jiangsu Province

Priority Academic Program Development of Jiangsu Higher Education Institutions

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference43 articles.

1. Binding of anterior gradient 2 and estrogen receptor-alpha: dual critical roles in enhancing fulvestrant resistance and IGF-1-induced tumorigenesis of breast cancer;Li;Cancer Lett.,2016

2. Downregulation of ACE2/Ang-(1-7)/Mas axis promotes breast cancer metastasis by enhancing store-operated calcium entry;Yu;Cancer Lett.,2016

3. The tumor microenvironment is a dominant force in multidrug resistance;Correia;Drug Resist. Updat.,2012

4. Inflammation and cancer;Coussens;Nature,2002

5. Pathways connecting inflammation and cancer;Allavena;Curr. Opin. Genet. Dev.,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineered Nanobodies Elicit Durable and Robust Bi‐Therapeutic Efficacy Toward Virus and Tumors;Advanced Functional Materials;2024-06-26

2. Targeted drug delivery using nanobodies to deliver effective molecules to breast cancer cells: the most attractive application of nanobodies;Cancer Cell International;2024-02-10

3. Promising Diagnostic and Therapeutic Approaches Based on VHHs for Cancer Management;Cancers;2024-01-15

4. Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy;Cell Death & Disease;2024-01-08

5. Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer;Frontiers in Immunology;2023-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3